They were pushed into the public consciousness a decade ago when former Vice President Dick Cheney had his replaced. News reports later said doctors had modified Cheney’s so it couldn’t be hacked.
Yes, they’re implantable cardioverter defibrillators—battery-operated devices implanted in the chest that help regulate heartbeats.
By now, defibrillators are more commonplace—so much so that the Medicare agency in mid-February said health-care providers no longer have to collect and transmit data on their implantations if they want Medicare to cover the procedure.
Industry and health-care provider groups looked upon the Medicare agency’s latest update of its process for covering the devices as a positive move.
Removing the mandatory collection and data transmission after years of collection on more than a million patients was a big win, Chandra Branham, vice president of payment and health-care delivery policy for the Advanced Medical Technology Association, told me. Among AdvaMed's members are those that make implantable devices.
Beneficiaries appeared to come out ahead, too.
Exceptions are now allowed to the required 90-day waiting periods before an implantation, such as for patients like Cheney who already have a device but qualify for a replacement.
Beneficiaries will also have to share in the decision-making about undergoing the process.
Doctors will have to use a “decision aid tool” designed to explain the risks for patients. The session is especially important for those who have complex health issues, the Medicare agency said.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)